Progress in understanding of prognostic impact of beta-blockers on patients with heart failure and atrial fibrillation
β-blockers are an important part of the "Golden Triangle" therapy for patients with heart failure (HF) and have been proven to be effective drugs in the treatment of chronic heart failure. The presence of atrial fibrillation (AF) may reduce or eliminate the prognostic benefit of beta-blockers, which are currently used more for symptom improvement and cardiac function. It is still controversial whether β-blockers can improve the prognosis of patients with both HF and AF. This article reviews the effect of β-blockers on the prognosis of patients with both HF and AF.
万方数据
